Precision BioSciences, Inc. Forecast, price target & analysts
Precision BioSciences, Inc. Target price 2025 - Analyst rating & recommendation
Precision BioSciences, Inc. Classifications & Recommendation:
Precision BioSciences, Inc. Price Target
| Target Price | $30.60 |
| Price | $6.14 |
| Potential |
398.37%
register free of charge
|
| Number of Estimates | 5 |
|
5 Analysts have issued a price target Precision BioSciences, Inc. 2026 .
The average Precision BioSciences, Inc. target price is $30.60.
This is
398.37%
register free of charge
$63.00
926.06%
register free of charge
$19.19
212.54%
register free of charge
|
|
| A rating was issued by 9 analysts: 8 Analysts recommend Precision BioSciences, Inc. to buy, 1 to hold and 0 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the Precision BioSciences, Inc. stock has an average upside potential 2026 of
398.37%
register free of charge
|
Sales and Margin forecast 2025, 2026 to 2031
| Dec '24 |
2025 Estimates |
|
|---|---|---|
| Revenue Million $ | 68.70 | 11.02 |
| 40.98% | 83.97% | |
| EBITDA Margin | -34.12% | -613.89% |
| 58.13% | 1,699.24% | |
| Net Margin | 10.44% | -624.03% |
| 108.29% | 6,079.20% |
5 Analysts have issued a sales forecast Precision BioSciences, Inc. 2025 . The average Precision BioSciences, Inc. sales estimate is
This results in the following potential growth metrics:
3 Analysts have issued an Precision BioSciences, Inc. EBITDA forecast 2025. The average Precision BioSciences, Inc. EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
5 Precision BioSciences, Inc. Analysts have issued a net profit forecast 2025. The average Precision BioSciences, Inc. net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Earnings per share, P/E ratio and EV/sales Estimates 2025, 2026 to 2031
| Dec '24 |
2025 Estimates |
|
|---|---|---|
| Earnings Per Share $ | 1.04 | -5.91 |
| 106.52% | 668.27% | |
| P/E | negative | |
| EV/Sales | 3.77 |
5 Analysts have issued a Precision BioSciences, Inc. forecast for earnings per share. The average Precision BioSciences, Inc. EPS is
This results in the following potential growth metrics and future valuations:
Precision BioSciences, Inc....
Current Precision BioSciences, Inc. Upgrades & Downgrades
| Analyst | Rating | Action | Date |
|---|---|---|---|
| HC Wainwright & Co. |
Locked
➜
Locked
|
Locked | May 21 2025 |
| HC Wainwright & Co. |
Locked
➜
Locked
|
Locked | Mar 28 2025 |
| HC Wainwright & Co. |
Locked
➜
Locked
|
Locked | Mar 19 2025 |
| HC Wainwright & Co. |
Locked
➜
Locked
|
Locked | Feb 19 2025 |
| BMO Capital |
Locked
➜
Locked
|
Locked | Jan 10 2025 |
| HC Wainwright & Co. |
Locked
➜
Locked
|
Locked | Jan 10 2025 |
| HC Wainwright & Co. |
Locked
➜
Locked
|
Locked | Aug 22 2024 |
| Analyst Rating | Date |
|---|---|
|
Locked
HC Wainwright & Co.:
Locked
➜
Locked
|
May 21 2025 |
|
Locked
HC Wainwright & Co.:
Locked
➜
Locked
|
Mar 28 2025 |
|
Locked
HC Wainwright & Co.:
Locked
➜
Locked
|
Mar 19 2025 |
|
Locked
HC Wainwright & Co.:
Locked
➜
Locked
|
Feb 19 2025 |
|
Locked
BMO Capital:
Locked
➜
Locked
|
Jan 10 2025 |
|
Locked
HC Wainwright & Co.:
Locked
➜
Locked
|
Jan 10 2025 |
|
Locked
HC Wainwright & Co.:
Locked
➜
Locked
|
Aug 22 2024 |
Discover more stocks with a high price target
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
